Physician profile
Glenn E Graves
NPI 1780671677
$687.95
in general payments reported to CMS, 2019-2025
10 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $51.59 · 2021: $47.66 · 2022: $70.54 · 2023: $46.43 · 2024: $245 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $218.06 | 2022-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Abbvie INC. | $161.10 | 2022-2024 | |
| Allergan, INC. | $80.72 | 2019-2021 | |
| Alcon Vision LLC | $57.04 | 2020-2025 | Hydrus Microstent |
| The Cameron-Ehlen Group, INC. | $47.08 | 2019 | |
| Sight Sciences, INC. | $37.75 | 2020-2021 | |
| Thea Pharma INC. | $24.82 | 2023 | Iyuzeh |
| Glaukos Corporation | $23.23 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.14 | 2019-2021 | |
| Rxsight INC | $16.01 | 2024 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.